{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_53435"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_53435","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"THE ROLE OF THE NRF2 SIGNALING PATHWAY IN CHLOROPICRIN-INDUCED CORNEAL INJURY IN VIVO","abstract":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Okoyeocha, Oluchukwu Ebenezar"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Tewari-Singh, Neera","Rockwell, Cheryl","Mohr, Susanne","Komaromy, Andras"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:53Z","subjects":["Pharmacology","Toxicology"],"languages":["eng"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53435","local:Okoyeocha_grad.msu_0128D_22504"],"render_values":[{"text":"etd:53435","href":null,"code":true},{"text":"local:Okoyeocha_grad.msu_0128D_22504","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/r7mz-8741","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/r7mz-8741","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_53435","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Tewari-Singh, Neera","Rockwell, Cheryl","Mohr, Susanne","Komaromy, Andras"]},{"key":"dc:creator","label":"Author","values":["Okoyeocha, Oluchukwu Ebenezar"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Pharmacology","Toxicology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53435","local:Okoyeocha_grad.msu_0128D_22504","https://doi.org/doi:10.25335/r7mz-8741"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2026","Chloropicrin (CP; CCl3NO2, trichloronitromethane) is a choking and tearing chemicalagent used historically during World War I and in subsequent chemical attacks. Today, CP is widely employed as an agricultural pesticide and soil fumigant, which increases its availability and raises concerns about potential misuse as a chemical threat or terrorist agent, along with occupational and environmental exposure risks. Exposure to CP often causes severe eye injuries, especially to the cornea. Previous in vitro studies from our lab have shown that CP exposure causes DNA damage, oxidative stress, and inflammation to the cornea, indicating that targeting oxidative stress and inflammation may be key to reducing CP-related eye injuries. However, progress in understanding CP toxicity has been limited due to the lack of an appropriate in vivo eye injury model. Therefore, this dissertation aimed to develop and characterize an in vivo model of CPinduced corneal injury and identify measurable clinical, cellular, and molecular markers of injury progression. Given that CP exposure is linked to oxidative stress and inflammation, we also explored the role of the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway, a vital regulator of antioxidant and cell-protective responses. We first developed a mouse model of CP-induced corneal injury using a vapor-only exposure system designed to simulate realistic human exposure scenarios. CP exposure caused a dose-dependent severity in ocular injury. Using 10% CP for further research, we tracked the injury progression and identified early-phase clinical markers, including corneal ulceration and eyelid swelling, and late-phase clinical markers, like corneal opacity and neovascularization. These clinical signs matched structural changes such as increased corneal thickness from stromal edema and transient epithelial thinning, followed by reepithelialization during healing. Transcriptomic analysis showed activation of inflammatory pathways, including cytokine–cytokine receptor interactions, Interleukin-17 (IL-17) signaling, Nuclear factor-κB (NF-κB) signaling, and complement cascades, along with decreased activity of metabolic and detoxification pathways. qPCR confirmed a rapid inflammatory response peaking within 24 hours after exposure and mostly resolving by day 7, though fibrotic and blood vessel formation signals persisted into later stages. Using Nrf2 knockout (KO) mice, we found that loss of Nrf2 worsens CP-induced corneal injury, leading to prolonged inflammation, increased immune cell infiltration, and slower epithelial healing compared to wild-type mice. These results suggest that the Nrf2 pathway plays a protective role against CP-induced ocular toxicity. Finally, we tested a therapy targeting the Nrf2 pathway using RTA 408 (omaveloxolone), an FDA-approved Nrf2 activator. Topical RTA 408 activated the NRF2 pathway and alleviated the severity of CP-induced corneal injury, especially in reducing ulceration. Future work will expand on these findings by using new methods to identify additional drug targets from transcriptomic data. We will also test other Nrf2 activators and explore combination treatments, including previously studied super-saturated oxygen emulsions. Overall, our studies have established a relevant in vivo model for CP eye injury and advanced strategies for treating CP-induced ocular damage. Additionally, these findings could guide the development of therapies for other chemical warfare agents and chemical threats causing similar eye injuries.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (127 p.) : ill."]},{"key":"dc:title","label":"Title","values":["THE ROLE OF THE NRF2 SIGNALING PATHWAY IN CHLOROPICRIN-INDUCED CORNEAL INJURY IN VIVO"]}]}],"canonical_facts":{"dc:contributor":["Tewari-Singh, Neera","Rockwell, Cheryl","Mohr, Susanne","Komaromy, Andras"],"dc:creator":["Okoyeocha, Oluchukwu Ebenezar"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Pharmacology and Toxicology-Environmental Toxicology - Doctor of Philosophy, 2026","Chloropicrin (CP; CCl3NO2, trichloronitromethane) is a choking and tearing chemicalagent used historically during World War I and in subsequent chemical attacks. Today, CP is widely employed as an agricultural pesticide and soil fumigant, which increases its availability and raises concerns about potential misuse as a chemical threat or terrorist agent, along with occupational and environmental exposure risks. Exposure to CP often causes severe eye injuries, especially to the cornea. Previous in vitro studies from our lab have shown that CP exposure causes DNA damage, oxidative stress, and inflammation to the cornea, indicating that targeting oxidative stress and inflammation may be key to reducing CP-related eye injuries. However, progress in understanding CP toxicity has been limited due to the lack of an appropriate in vivo eye injury model. Therefore, this dissertation aimed to develop and characterize an in vivo model of CPinduced corneal injury and identify measurable clinical, cellular, and molecular markers of injury progression. Given that CP exposure is linked to oxidative stress and inflammation, we also explored the role of the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway, a vital regulator of antioxidant and cell-protective responses. We first developed a mouse model of CP-induced corneal injury using a vapor-only exposure system designed to simulate realistic human exposure scenarios. CP exposure caused a dose-dependent severity in ocular injury. Using 10% CP for further research, we tracked the injury progression and identified early-phase clinical markers, including corneal ulceration and eyelid swelling, and late-phase clinical markers, like corneal opacity and neovascularization. These clinical signs matched structural changes such as increased corneal thickness from stromal edema and transient epithelial thinning, followed by reepithelialization during healing. Transcriptomic analysis showed activation of inflammatory pathways, including cytokine–cytokine receptor interactions, Interleukin-17 (IL-17) signaling, Nuclear factor-κB (NF-κB) signaling, and complement cascades, along with decreased activity of metabolic and detoxification pathways. qPCR confirmed a rapid inflammatory response peaking within 24 hours after exposure and mostly resolving by day 7, though fibrotic and blood vessel formation signals persisted into later stages. Using Nrf2 knockout (KO) mice, we found that loss of Nrf2 worsens CP-induced corneal injury, leading to prolonged inflammation, increased immune cell infiltration, and slower epithelial healing compared to wild-type mice. These results suggest that the Nrf2 pathway plays a protective role against CP-induced ocular toxicity. Finally, we tested a therapy targeting the Nrf2 pathway using RTA 408 (omaveloxolone), an FDA-approved Nrf2 activator. Topical RTA 408 activated the NRF2 pathway and alleviated the severity of CP-induced corneal injury, especially in reducing ulceration. Future work will expand on these findings by using new methods to identify additional drug targets from transcriptomic data. We will also test other Nrf2 activators and explore combination treatments, including previously studied super-saturated oxygen emulsions. Overall, our studies have established a relevant in vivo model for CP eye injury and advanced strategies for treating CP-induced ocular damage. Additionally, these findings could guide the development of therapies for other chemical warfare agents and chemical threats causing similar eye injuries.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (127 p.) : ill."],"dc:identifier":["etd:53435","local:Okoyeocha_grad.msu_0128D_22504","https://doi.org/doi:10.25335/r7mz-8741"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:subject":["Pharmacology","Toxicology"],"dc:title":["THE ROLE OF THE NRF2 SIGNALING PATHWAY IN CHLOROPICRIN-INDUCED CORNEAL INJURY IN VIVO"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:53Z"}